Is it possible to reduce endoscopy workload using age, alarm symptoms and H. pylori as predictors of peptic ulcer and oesophagogastric cancers?

Digestive and Liver Disease

Volumn 37, Issue 7, 2005, Pages 526-532

  Voutilainen, M ^a   Mantynen T ^b   Mauranen, K ^c   Kunnamo, I ^b   Juhola, M ^a  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b Karstula Health Care Centre   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alarm symptoms; Gastroscopy; H. pylori; Oesophagogastric cancer; Peptic ulcer

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ARTICLE; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT REFERRAL; PEPTIC ULCER; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SEX DIFFERENCE; STOMACH CANCER; SYMPTOM; WEIGHT REDUCTION; WORKLOAD; CROSS-SECTIONAL STUDY; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS TUMOR; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE; STOMACH TUMOR; UTILIZATION REVIEW;

AGE FACTORS; CROSS-SECTIONAL STUDIES; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER; REFERRAL AND CONSULTATION; ROC CURVE; STOMACH NEOPLASMS;

EID: 26944470045     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.01.012     Document Type: Article

References (30)

1. Talley N., Silverstein M., Agréus L., Nyrén O., Sonnenberg A., and Holtmann G. AGA technical review: evaluation of dyspepsia. Gastroenterology 114 (1998) 582-595
2. Veldhuyzen van Zanten S., Flook N., Chiba N., Armstrong D., Barkun A., Bradette M., et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Can Med Assoc J 162 12 Suppl. (2000) S3-S23
3. Sue-Ling H., Johnston D., Martin I., Dixon M., Lansdown M., McMahon M., et al. Gastric cancer: a curable disease in Britain. Br Med J 307 (1993) 591-596
4. van Sandick J.W., van Lanschot J.J.B., Kuiken B.W., Tytgat G.N.J., Offerhaus G.J.A., and Obertop H. The impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
5. Logan R., and Delaney B. Implications of dyspepsia for the NHS. Br Med J 323 (2001) 675-677
6. Moayyedi P., Zilles A., Clough M., Hemingbrough E., Chalmers D., and Axon A. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. Eur J Gastroenterol Hepatol 11 (1999) 1245-1250
7. Heaney A., Collins J., Watson R., McFarland R., Bamford K., and Tham T. A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 45 (1999) 186-190
8. Spiegel B., Vakil N., and Ofman J. Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 122 (2002) 1270-1285
9. Breslin N., Thomson A., Bailey R., Blustein P., Meddings J., Lalor E., et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 46 (2000) 93-97
10. Bramble M., Suvakovic Z., and Hungin A. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 46 (2000) 464-467
11. Mäntynen T., Färkkilä M., Kunnamo I., Mecklin J.-P., Juhola M., and Voutilainen M. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its' complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 97 (2002) 2524-2529
12. Voutilainen M., Mäntynen T., Kunnamo I., Juhola M., Mecklin J.-P., and Färkkilä M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol 38 (2003) 109-113
13. Henry D., Lim L.L.-Y., Rodriguez L.A.G., Gutthann S.P., Carson J.L., Griffin M., et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 312 (1996) 1563-1566
14. Anonymous. Guidelines for clinical trials in Helicobacter pylori infection. Working party of the European Helicobacter pylori study group. Gut 1997;41(Suppl. 2):S1-9.
15. Lieberman D., De Garmo P., Fleischer D., Eisen G., and Helfand M. Patterns of endoscopy use in the United States. Gastroenterology 118 (2000) 619-624
16. Wallace M., Durkalski V., Vaughan J., Palesch Y., Libby E., Jowell P., et al. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 49 (2001) 29-34
17. Delaney BC, Moayyedi PDF. Initial management strategies for dyspepsia (Cochrane review). In: The Cochrane Library; 2003(2).
18. Meineche-Schmidt V., and Christensen E. Which dyspepsia patients will benefit from omeprazole treatment?. Am J Gastroenterol 95 (2000) 2777-2783
19. Weijnen C., Numans M., de Wit N., Smout A., Moons K., Verheij T., et al. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study. Br Med J 323 (2001) 71-75
20. Delaney B., Wilson S., Roalfe A., Roberts L., Redman V., Wearn A., et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 356 (2000) 1965-1969
21. Moayyedi P, Soo S, Deeks J, Delaney BC, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia (Cochrane Review). In: The Cochrane Library; 2003(1).
22. Christie J., Shepherd N., Codling B., and Valori R. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 41 (1997) 513-517
23. Färkkilä M., Sarna S., Valtonen V., Sipponen P., and PROSPER Study Group. Does the "test-and-treat" strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. Scand J Gastroenterol 39 (2004) 327-335
24. Gomollon F., Ducons J.A., Santolaria S., Lera Omiste I., Guirao R., Ferrero M., et al. Breath test is very reliable for diagnosis of Helicobacter pylori infection in real clinical practice. Dig Liver Dis 35 (2003) 612-618
25. Moayyedi P., and Axon A. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 94 (1999) 3122-3125
26. Lagergren J., Bergström R., Lindgren A., and Nýren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
27. Schindlbeck N.E., Klauser A.G., Voderholzer W.A., and Müller-Lissner S.A. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 155 (1995) 1808-1812
28. Johnsson F., Weywadt L., Solhaug J.H., and Hernqvist H.L.B. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 33 (1998) 15-20
29. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., Festen H.P.M., Jansen E.H., Tuynman H.A.R.E., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 92 (1997) 1997-2000
30. Fass R., Ofman J.J., Gralnek I.M., Johnson C., Camargo E., Sampliner R.E., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 159 (1999) 2161-2168